Japan's health ministry will on Wednesday file a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, Kyodo News agency reported.
Novartis Pharma KK has been under fire since a university said the data in clinical studies might have been skewed to promote Valsartan.
Health Minister Norihisa Tamura has characterised as "extremely regrettable" the incident in which an employee of the world's number two drug maker hid his affiliation during a medical study into the effects of the drug used to lower blood pressure.
Under Japan's pharmaceutical law, anyone found guilty of exaggerated advertising can be punished with up to two years' prison or a fine of up to two million yen ($19,400).
It would be the first time a criminal complaint has been filed in Japan over exaggerated pharmaceutical advertising, Kyodo said, quoting ministry officials. Full story...
Related posts:
Novartis Pharma KK has been under fire since a university said the data in clinical studies might have been skewed to promote Valsartan.
Health Minister Norihisa Tamura has characterised as "extremely regrettable" the incident in which an employee of the world's number two drug maker hid his affiliation during a medical study into the effects of the drug used to lower blood pressure.
Under Japan's pharmaceutical law, anyone found guilty of exaggerated advertising can be punished with up to two years' prison or a fine of up to two million yen ($19,400).
It would be the first time a criminal complaint has been filed in Japan over exaggerated pharmaceutical advertising, Kyodo said, quoting ministry officials. Full story...
Related posts:
- Japan pursues Novartis unit over 'fake' drug data...
- Novartis eye care unit hit by China bribery claims...
- Japanese university to retract Novartis study for fabricated data...
- Novartis under fire over false Japanese drug data...
- Novartis hit by second US lawsuit in four days...
- India's Supreme Court rejects patent for cancer drug from pharma giant Novartis...
- Germany fourth country to ban Novartis flu vaccine...
- Novartis chairman’s golden payoff slammed...
No comments:
Post a Comment